Newsroom | 39594 results

BAAR, Switzerland--(BUSINESS WIRE)--Novocure to Participate in 2026 Leerink Global Healthcare Conference...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers announced today that it will participate in TD Cowen’s 46th Annual Health Care Conference, taking place March 2-4, 202...

PLAINVIEW, N.Y.--(BUSINESS WIRE)--Three pathology and healthcare technology leaders today announced a partnership that has resulted in the installation of the first LH510 Digital Pathology scanner in the United States, marking a significant milestone in the advancement of digital pathology and diagnostic innovation. This landmark installation represents an important step forward in expanding access to high-quality digital pathology solutions in the U.S. Through close collaboration, the partners...

NEW ORLEANS--(BUSINESS WIRE)--Medsynaptic, a global provider of enterprise imaging and PACS solutions, today announced its participation in the AAOS Annual Meeting....

SAMARATE, Italy--(BUSINESS WIRE)--Quanta System Sp.A., a leading company in laser technologies for surgery, dermatology, and aesthetic medicine, 100% Made in Italy and part of the El.En. Group, announced today the establishment of Quanta System Inc., a new US entity based in North Carolina, officially operational as of March 1, 2026. The creation of a direct presence in the US Surgical and Urology market, represents a strategic step in the international expansion of the organization. By launchi...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon presents results from new VTAMA sub-analysis showing early and consistent improvement in atopic dermatitis patient-reported sleep subdomains....

SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence (UUI), today announced that three-year results from the pivotal OASIS study were presented by Roger Dmochowski, M.D., Chief Medical Officer, BlueWind Medical, at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2026 Winter Meeting. The data confirm Rev...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated February 2, 2026, it has surpassed the Minimum Subscription and closed on an Initial Closing of $2,700,000 of the non-brokered Private Placement to accredited investors. The Private Placement is for up to $5,000,000 by issuance of up to 100 Convertible Loan Notes, each with a face value of $50,000 (“Series IV Notes”). The Series IV Notes...

GENF--(BUSINESS WIRE)--Das Wyss Center for Bio and Neuroengineering Geneva gab heute den erfolgreichen Abschluss der Startkapital-Finanzierungsrunde für Clee Medical SA bekannt, ein Schweizer Spin-off-Unternehmen im Bereich Neurotechnologie, das ultrahochauflösende Echtzeit-Bildgebung für die Gehirnchirurgie entwickelt. Die Runde wurde vom High-Tech Gründerfonds (HTGF) angeführt, unter Beteiligung der Zürcher Kantonalbank (ZKB), Kickfund, FONGIT und Venture Kick, die sich den bestehenden Invest...

GINEBRA, Suiza--(BUSINESS WIRE)--Wyss Center for Bio and Neuroengineering Geneva anunció hoy el cierre exitoso de la ronda de financiación semilla de Clee Medical SA, una empresa derivada de neurotecnología suiza que desarrolla imágenes intraoperatorias en tiempo real de alta resolución para cirugías cerebrales. La ronda fue liderada por High-Tech Gründerfonds (HTGF) y contó con la participación de Zürcher Kantonalbank (ZKB), Kickfund, FONGIT y Venture Kick, que se unieron a los inversores exis...